A Randomized, Single‐Blind, Placebo‐Controlled, 3‐Way Crossover Study to Evaluate the Effect of Therapeutic and Supratherapeutic Doses of Edaravone on QT/QTc Interval in Healthy Su...

por Shimizu, Hidetoshi, Inoue, Shinsuke, Endo, Mai, Nakamaru, Yoshinobu, Yoshida, Kaori, Natori, Tomoko, Kakubari, Masae, Akimoto, Makoto, Kondo, Kazuoki
Publicado 2020

Evaluation of Pharmacokinetics, Safety, and Drug‐Drug Interactions of an Oral Suspension of Edaravone in Healthy Adults

por Shimizu, Hidetoshi, Nishimura, Yukiko, Shiide, Yoichi, Matsuda, Hideaki, Akimoto, Makoto, Matsuda, Munetomo, Nakamaru, Yoshinobu, Kato, Yuichiro, Kondo, Kazuoki
Publicado 2021

Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients

por Abe, Koji, Itoyama, Yasuto, Sobue, Gen, Tsuji, Shoji, Aoki, Masashi, Doyu, Manabu, Hamada, Chikuma, Kondo, Kazuoki, Yoneoka, Takatomo, Akimoto, Makoto, Yoshino, Hiide
Publicado 2014